• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
LI Lili, WANG Hongpeng, TIAN Haiwei, LI Jin, GAO Shuangshuang, HA Jing. Determination of 6 residual solvents in selexipag by headspace gas chromatography[J]. Journal of China Pharmaceutical University, 2018, 49(1): 93-96. DOI: 10.11665/j.issn.1000-5048.20180113
Citation: LI Lili, WANG Hongpeng, TIAN Haiwei, LI Jin, GAO Shuangshuang, HA Jing. Determination of 6 residual solvents in selexipag by headspace gas chromatography[J]. Journal of China Pharmaceutical University, 2018, 49(1): 93-96. DOI: 10.11665/j.issn.1000-5048.20180113

Determination of 6 residual solvents in selexipag by headspace gas chromatography

More Information
  • A headspace gas chromatography method was developed for the determination of six residual solvents including methanol, ethanol, acetone, dichloromethane, tetrahydrofuran and toluene residues in selexipag to provide the experimental basis for its quality control. The samples were separated on Kromat PC-624(V)silica capillary column(30. 0 m×0. 32 mm, 1. 8 μm)using temperature programming. The column temperature was kept at 40 °C for 5 min initially, and then raised to 180 °C at the rate of 20 °C /min and subsequently sustained for 5 min. FID detector temperature was 250 °C and injection temperature was 200 °C. The split ratio was 20 ∶1. The six residual solvents are separated completely under the given chromatographic conditions with a good linearity(r=0. 998 2-1. 000); the results of precision, repeatability and stability experiments met the requirement, and the mean recoveries of all solvents were in the range of 96. 67%-101. 7%. The analytical method is simple, accurate and sensitive, and it can be used for the determination of residual solvents in selexipag.
  • [1]
    Liu YG,Zhao LJ,Xiao GZ,et al.Selexipag[J].Drugs Clin(现代药物与临床),2010,25(6):469-471.
    [2]
    Du C,Liu YX.Selexipag[J].Chin J Med Chem(中国药物化学杂志),2016,26(4):352.
    [3]
    Xia XM.FDA approved Uptarvi(selexipag)tablets in the treatment of pulmonary arterial hypertension[J].J Guangdong Pharm Univ(广东药学院学报),2016,32(1):35.
    [4]
    Wang H.Study on the synthesis of selexipag(Selexipag的工艺研究)[D].Shijiazhuang:Hebei University of Science and Technology,2017.
    [5]
    Shang ZH,Wang H,Fang Q.Method for preparing selexipag:CN,201610357729.3[P].2016-06-20[2017-07-15] .
    [6]
    Chinese Pharmacopoeia Commission.Chinese Pharmacopoeia:part 4[S].(中华人民共和国药典:四部),Beijing:China Medical Science Press,2015:105-109.
    [7]
    Ito Y,Ishizuki K,Sekiguchi W,et al.Analysis of residual solvents in annatto extracts using a static headspace gas chromatography method[J].Ameri J Analy Chem,2012,3(9):638-645.
    [8]
    Teglia CM,Montemurro M,Zan MMD,et al.Multiple responses optimization in the development of a headspace gas chromatography method for the determination of residual solvents in pharmaceuticals[J].J Pharm Anal,2015,5(5):296-306.
    [9]
    Grodowska K,Parczewski A.Grouping of residual solvents present in pharmaceuticals using experimental planning and chemometric methods[J].Acta Poloniae Pharm,2013,70(2):191-203.
    [10]
    Cheng C,Liu S,Mueller B J,et al.A generic static headspace gas chromatography method for determination of residual solvents in drug substance[J].J Chromatogr A,2010,1217(41):6413-6421.
    [11]
    Huang R,Zhang SJ,Huang LY.Determination of residual organic solvents in fenazinel dihydrochloride by headspace gas chromatography[J].J China Pharm Univ(中国药科大学学报),2008,39(2):183-184.
  • Related Articles

    [1]LIU Li, LIU Zijin, TANG Jun, HE Guangwei, LIU Weizhong. Optimized synthesis process of tofacitinib citrate[J]. Journal of China Pharmaceutical University, 2022, 53(6): 685-689. DOI: 10.11665/j.issn.1000-5048.20220606
    [2]WU Xufeng, CHAI Shiying, LIU Jianhong, WANG Zhihui, YIN Ruifeng, CAO Ruiwei, SUN Xinqiang. Improvement of synthetic route of brivudine[J]. Journal of China Pharmaceutical University, 2022, 53(1): 41-45. DOI: 10.11665/j.issn.1000-5048.20220106
    [3]WANG Dong, ZHONG Jian, WANG Ling, ZHOU Zhihui, JIANG Haiting, LUO Peng, WANG Xizhi, WANG Chongyi. Improved synthetic process of apremilast[J]. Journal of China Pharmaceutical University, 2021, 52(5): 536-540. DOI: 10.11665/j.issn.1000-5048.20210504
    [4]HAN Chengqun, ZOU Qiaogen, SUN Qian, XIA Yunyan. Improvement of synthesis process of mirabegron[J]. Journal of China Pharmaceutical University, 2020, 51(4): 449-453. DOI: 10.11665/j.issn.1000-5048.20200409
    [5]ZHANG Qiuyue, YOU Qidong, YANG Jinpeng. Process improvement on the synthesis of atomoxetine[J]. Journal of China Pharmaceutical University, 2019, 50(4): 405-409. DOI: 10.11665/j.issn.1000-5048.20190404
    [6]LIU Li, WANG Chen, LIU Lixin, JI Tingting. Improved synthesis of analgesic pentazocine[J]. Journal of China Pharmaceutical University, 2018, 49(5): 568-571. DOI: 10.11665/j.issn.1000-5048.20180508
    [7]MA Li, ZHANG Menghan, XU Zhiwei, SUN Ying′ai, ZHU Jing, HUANG Yingbo, ZHANG Dayong. A new synthetic process of dapagliflozin[J]. Journal of China Pharmaceutical University, 2017, 48(1): 42-45. DOI: 10.11665/j.issn.1000-5048.20170106
    [8]WEI Qingjie, QIAO Junhua, CHEN Jianjun, GAO Zhigang, LI Yaqing. An improvement for synthesis of ceftriaxone sodium[J]. Journal of China Pharmaceutical University, 2016, 47(2): 163-165. DOI: 10.11665/j.issn.1000-5048.20160206
    [9]Improve on the Synthetic Process of Bezafibrate[J]. Journal of China Pharmaceutical University, 2003, (3): 80-81.
    [10]Improved Process of Nimodipine[J]. Journal of China Pharmaceutical University, 1998, (3): 82-83.
  • Cited by

    Periodical cited type(3)

    1. 李雨晴,邹师琪,傅伟淇,杨欣. 基于网络药理学和分子对接探讨陈皮治疗非小细胞肺癌的作用机制. 中华生物医学工程杂志. 2024(04): 266-272 .
    2. 高杰,丁留成,卫中庆. 脂质代谢在去势抵抗性前列腺癌中的研究进展. 东南国防医药. 2021(02): 169-174 .
    3. 赵帅华,董卫红,杨敬,韩保卫. ABHD5过表达对结肠癌细胞侵袭、迁移及AMPK/mTOR通路的影响. 中国普外基础与临床杂志. 2021(07): 850-855 .

    Other cited types(2)

Catalog

    Article views (781) PDF downloads (1092) Cited by(5)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return